Market Study Report LLC

Circulating Tumor Cells Market Size, Analysis, Competitive Strategies and Forecasts to 2024

The Study On The Global Market For Circulating Tumor Cells Market Evaluates Historical And Current Performance Of This Market, Especially Highlighting The Key Trends And Growth Opportunities. According To The Study, The Rising Demand For This Product Is Driving The Global Market For Global Circulating Tumor Cells Market Significantly. The Expansion In The Various Related Industry Is Also Expected To Reflect Positively On The Sales Of Global Circulating Tumor Cells Market Product Over The Next Few Years.

 

Selbyville, DE -- (SBWIRE) -- 06/18/2019 -- The global Circulating Tumor Cells market is valued at 730 million in 2018 and is expected to reach 2200 million by the end of 2024, growing at a CAGR of 20.1% between 2019 and 2024.

Request a sample of this premium report titled Global Circulating Tumor Cells Market 2019 by Company, Regions, Type and Application, Forecast to 2024 at: https://www.marketstudyreport.com/request-a-sample/1689514?utm_source=releasewire.com&utm_medium=ADS

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

Scope of the Report:

USA is the largest supplier of CTCs Products, with a revenue market share nearly 47.41% in 2017. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 26.24% in 2017. Asia has the highest growth rate. Vendors recognize the importance of this region, particularly in China, India and are working towards penetrating this market by strengthening their sales and distribution networks.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Circulating Tumor Cells.

This report studies the Circulating Tumor Cells market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Circulating Tumor Cells market by product type and applications/end industries.

Market Segment by Companies, this report covers:
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc

Market Segment by Regions, regional analysis covers:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers:
CTC Enrichment
CTC Detection
CTC Analysis

Market Segment by Applications, can be divided into:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other

Request a discount on standard prices of this premium report titled Global Circulating Tumor Cells Market 2019 by Company, Regions, Type and Application, Forecast to 2024 at: https://www.marketstudyreport.com/check-for-discount/1689514?utm_source=releasewire.com&utm_medium=ADS

Table of Contents:

1 Circulating Tumor Cells Market Overview

1.1 Product Overview and Scope of Circulating Tumor Cells
1.2 Classification of Circulating Tumor Cells by Types
1.2.1 Global Circulating Tumor Cells Revenue Comparison by Types (2019-2024)
1.2.2 Global Circulating Tumor Cells Revenue Market Share by Types in 2018
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.2.5 CTC Analysis
1.3 Global Circulating Tumor Cells Market by Application
1.3.1 Global Circulating Tumor Cells Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Other
1.4 Global Circulating Tumor Cells Market by Regions
1.4.1 Global Circulating Tumor Cells Market Size (Million ) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Circulating Tumor Cells Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells Status and Prospect (2014-2024)
1.5 Global Market Size of Circulating Tumor Cells (2014-2024)

2 Manufacturers Profiles
2.1 Menarini-Silicon Biosystems
2.1.1 Business Overview
2.1.2 Circulating Tumor Cells Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.2 Qiagen (Adnagen)
2.2.1 Business Overview
2.2.2 Circulating Tumor Cells Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.3 Advanced Cell Diagnostics
2.3.1 Business Overview
2.3.2 Circulating Tumor Cells Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.4 ApoCell
2.4.1 Business Overview
2.4.2 Circulating Tumor Cells Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.5 Epic Sciences
2.5.1 Business Overview
2.5.2 Circulating Tumor Cells Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.6 Greiner Bio-one GmbH
2.6.1 Business Overview
2.6.2 Circulating Tumor Cells Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.7 Cynvenio
2.7.1 Business Overview
2.7.2 Circulating Tumor Cells Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.8 SurExamBio-Tech
2.8.1 Business Overview
2.8.2 Circulating Tumor Cells Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.9 Fluxion Biosciences
2.9.1 Business Overview
2.9.2 Circulating Tumor Cells Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.10 Ikonisys
2.10.1 Business Overview
2.10.2 Circulating Tumor Cells Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hangzhou Watson Biotech
2.11.1 Business Overview
2.11.2 Circulating Tumor Cells Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.12 Biocept
2.12.1 Business Overview
2.12.2 Circulating Tumor Cells Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.13 CytoTrack
2.13.1 Business Overview
2.13.2 Circulating Tumor Cells Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.14 Guangzhou Wondfo Biotech
2.14.1 Business Overview
2.14.2 Circulating Tumor Cells Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.15 Celsee
2.15.1 Business Overview
2.15.2 Circulating Tumor Cells Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.16 Clearbridge Biomedics
2.16.1 Business Overview
2.16.2 Circulating Tumor Cells Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)
2.17 ANGLE plc
2.17.1 Business Overview
2.17.2 Circulating Tumor Cells Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2017-2018)

3 Global Circulating Tumor Cells Market Competition, by Players
3.1 Global Circulating Tumor Cells Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cells Players Market Share
3.2.2 Top 10 Circulating Tumor Cells Players Market Share
3.3 Market Competition Trend

4 Global Circulating Tumor Cells Market Size by Regions
4.1 Global Circulating Tumor Cells Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
4.3 Europe Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
4.5 South America Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2014-2019)

5 North America Circulating Tumor Cells Revenue by Countries
5.1 North America Circulating Tumor Cells Revenue by Countries (2014-2019)
5.2 USA Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
5.3 Canada Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
5.4 Mexico Circulating Tumor Cells Revenue and Growth Rate (2014-2019)

6 Europe Circulating Tumor Cells Revenue by Countries
6.1 Europe Circulating Tumor Cells Revenue by Countries (2014-2019)
6.2 Germany Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
6.3 UK Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
6.4 France Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
6.5 Russia Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
6.6 Italy Circulating Tumor Cells Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Circulating Tumor Cells Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cells Revenue by Countries (2014-2019)
7.2 China Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
7.3 Japan Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
7.4 Korea Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
7.5 India Circulating Tumor Cells Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2014-2019)

Questions? Get them answered via https://www.marketstudyreport.com/enquiry-before-buying/1689514?utm_source=releasewire.com&utm_medium=ADS before taking a buying decision on this premium report titled Global Circulating Tumor Cells Market 2019 by Company, Regions, Type and Application, Forecast to 2024

About Market Study Report
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog